AQR Capital Management
VMD icon

AQR Capital Management’s Viemed Healthcare VMD Stock Holding History

AQR Capital Management’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Buy
205,480
+91,740
+81% +$908K ﹤0.01% 2524
2026
Q1 		$1.05M Buy
113,740
+65,440
+135% +$545K ﹤0.01% 2741
2025
Q4 		$359K Sell
48,300
-82
-0.2% -$562 ﹤0.01% 3091
2025
Q3 		$329K Buy
48,382
+20,409
+73% +$138K ﹤0.01% 3037
2025
Q2 		$193K Buy
27,973
+15,642
+127% +$106K ﹤0.01% 3057
2025
Q1 		$89.8K Buy
+12,331
New +$96.8K ﹤0.01% 3027
2022
Q1 		– Sell
-15,043
Closed -$79K – 2304
2021
Q4 		$79K Hold
15,043
– – ﹤0.01% 2162
2021
Q3 		$83K Buy
+15,043
New +$97.9K ﹤0.01% 2210
2021
Q2 		– Sell
-95,420
Closed -$966K – 2305
2021
Q1 		$966K Buy
95,420
+10,085
+12% +$94.9K ﹤0.01% 1565
2020
Q4 		$662K Buy
85,335
+35,521
+71% +$313K ﹤0.01% 1684
2020
Q3 		$430K Buy
+49,814
New +$503K ﹤0.01% 1794

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

AQR Capital Management's VMD Position: Q2 2026 in Review

AQR Capital Management increased its Viemed Healthcare (VMD) stake by 81% in Q2 2026, buying an estimated $908K and bringing the position to 205,480 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2524.

AQR Capital Management first reported a position in VMD in Q3 2020 and has held it in 11 quarters since. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • AQR Capital Management held 205,480 shares of Viemed Healthcare worth $2.34M as of Q2 2026.
  • AQR Capital Management bought 91,740 Viemed Healthcare shares in Q2 2026, an estimated $908K.
  • Viemed Healthcare made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #2524 holding.
  • AQR Capital Management first reported a position in Viemed Healthcare in Q3 2020 and has held it in 11 quarters since.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.